Analgesics - US - July 2013
US $4,395.00 (Excl.Tax)Excl. Tax Buy Now
“Product recalls from major brands have plagued the market for OTC analgesic remedies, causing consumers to turn to private label brands, external ways to treat pain, and alternative remedies. Brands can consider various new product innovations as well as using social media to connect with consumers.”
– Emily Krol, Health and Wellness Analyst
Some questions answered in this report include:
Despite more than eight in 10 respondents experiencing pain within the past six months, sales of OTC internal and external analgesics are expected to increase only 2% from 2012-13. Limited growth in this market can be attributed to more people choosing alternative ways to treat their pain.
However, the growing market of an aging population bodes well for the market of OTC analgesics, as does the prevalence of people with obesity. Both of these demographic groups over index for arthritis, and in turn require pain medications. Furthermore, the prevalence of stress, especially among women, increases the likelihood of experiencing headaches and back pains, bodes well for the market. A return to shelf of Johnson & Johnson brands Tylenol and Motrin, as well as Novartis AG’s Excedrin will cause both store brands and other competitors to vie for consumer loyalty.
This report will help readers to understand consumer usage of OTC internal and external analgesics by demographics. It will also reveal levels of brand loyalty illustrate consumer interest in private label brands. The report also compares consumer preferences for OTC internal vs. external analgesics, and whether there is an opportunity for a combination remedy that offers immediate and long-lasting relief. Readers of the report will understand how product recalls have impacted the market of internal and external analgesics.
The report also analyzes marketing strategies of major players within the OTC analgesics market, as well as product innovations and trends. Readers of the report will gain valuable insights and recommendations which can be applied to growing the category of OTC analgesics.
This report focuses on the market for internal and external analgesics specifically marketed for pain relief that are available over the counter/without a prescription.
Internal analgesics are ingestible/oral tablets or liquid. Products within this market typically contain one or more of the following active ingredients:
The OTC external analgesics segment consists of rubs – such as topical creams/sprays that alleviate pain – wraps, with heating and/or cooling properties, as well as heat/ice packs.
Products intended for use as arthritis relief, migraine relief, Premenstrual syndrome (PMS), and combination sleep aid/pain relief products also are included. Note that feminine pain relievers are primarily tablets, but are split out because these products cater to a niche market. Products for children are included, though they are not the main focus of this report.
Mintel’s consumer reports deliver insight and expert analysis into key consumer trends and behaviour in your marketplace, in addition to an overview of the market data and key brands. Mintel’s consumer reports provide you with easily digestible information to guide your future innovation and move your business forward.Download now
This report will give you a complete 360-degree view of your market. Not only is it rooted in robust proprietary and high-quality third-party data, but our industry experts put that data into context and you’ll quickly understand:
What They Want. Why They Want It.
Who’s Winning. How To Stay Ahead.
Size, Segments, Shares And Forecasts: How It All Adds Up.
New Ideas. New Products. New Potential.
Where The White Space Is. How To Make It Yours.
What’s Shaping Demand – Today And Tomorrow.